CIK 0001411685 · Non-accelerated filer<br>Smaller reporting company
Vistagen Therapeutics, Inc.
Sign in to watch- Ticker
- VTGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 205093315
- Phone
- 650-577-3600
- Business address
- 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Excaliber Enterprises, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 51 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-29 | Williamson Douglas J Director | Grant or award · Stock Options (Right to Buy) | +40,826 | 40,826 | ||
| 2026-06-30 | Adler Reid G. Chief Legal Officer | Grant or award | +36,818 | $0.19 | $7K | 60,868 |
| 2026-06-30 | Tressler Nick B. Chief Financial Officer | Grant or award | +11,712 | $0.19 | $2K | 11,712 |
| 2026-06-30 | Singh Shawn President and CEO | Grant or award | +36,818 | $0.19 | $7K | 54,846 |
| 2026-05-18 | Angelov Angel S Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2026-04-07 | Cote Elissa S. Chief Corp Development Officer | Grant or award · Incentive Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2026-04-07 | Prince Joshua S. Chief Operating Officer | Grant or award · Incentive Stock Option (right to buy) | +18,752 | 18,752 | ||
| 2026-04-07 | Prince Joshua S. Chief Operating Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +56,248 | 56,248 | ||
| 2026-04-07 | Adler Reid G. Chief Legal Officer | Grant or award · Incentive Stock Option (right to buy) | +18,753 | 18,753 | ||
| 2026-04-07 | Adler Reid G. Chief Legal Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +56,247 | 56,247 | ||
| 2026-04-07 | Tressler Nick B. Chief Financial Officer | Grant or award · Incentive Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2026-04-07 | Singh Shawn President and CEO | Grant or award · Incentive Stock Option (right to buy) | +3,732 | 3,732 | ||
| 2026-04-07 | Singh Shawn President and CEO | Grant or award · Non-Qualified Stock Option (right to buy) | +71,268 | 71,268 | ||
| 2025-12-31 | Prince Joshua S. Chief Operating Officer | Grant or award | +4,386 | $0.56 | $2K | 15,249 |
| 2025-12-01 | Tressler Nick B. Chief Financial Officer | Grant or award · Common Stock (Right to Buy) | +150,000 | 150,000 | ||
| 2025-10-27 | Edick Paul R Director | Grant or award · Stock Option (Right to Buy) | +35,200 | 35,200 | ||
| 2025-09-09 | SAXE JON S Director | Grant or award · Non-Qualified Stock Option (right to buy) | +17,600 | 17,600 | ||
| 2025-09-09 | Rotunno Mary L. Director | Grant or award · Non-Qualified Stock Option (right to buy) | +17,600 | 17,600 | ||
| 2025-09-09 | FitzPatrick Margaret M Director | Grant or award · Non-Qualified Stock Option (right to buy) | +17,600 | 17,600 | ||
| 2025-09-09 | Curley Joanne Director | Grant or award · Non-Qualified Stock Option (right to buy) | +17,600 | 17,600 |
Page 1 of 17 · 323 trades